A Study of S-606001 as Monotherapy in Participants With Late-onset Pompe Disease (LOPD)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The primary purpose of this study is to evaluate the safety and tolerability profile of S-606001 in participants with LOPD.
Epistemonikos ID: 22683dab1be90718465e74a7600447978e4a0741
First added on: Aug 26, 2026